M. Chen

发表

Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial.

M. Chen, R. Livingston, L. Einhorn, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized, double-blind phase III study of pazopanib in treatment-naive and cytokine-pretreated patients with advanced renal cell carcinoma (RCC).

C. Sternberg, I. Davis, C. Szczylik, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The treatment of massive hepatomegaly in stage IV-S neuroblastoma.

R. Peschel, J. Seashore, M. Chen, 1981, International journal of radiation oncology, biology, physics.

Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial

Wei Chen, Z. Zhou, Y. Shyr, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

LBA43 GEMSTONE-301: A randomized, double-blind, placebo-controlled, phase III study of sugemalimab in patients with unresectable stage III non-small cell lung cancer (NSCLC) who had not progressed after concurrent or sequential chemoradiotherapy (CRT)

Q. Wang, N. Cui, Y. Wu, 2021, Annals of Oncology.

Pembrolizumab in microsatellite instability high cancers: Updated analysis of the phase II KEYNOTE-164 and KEYNOTE-158 studies

D. Jäger, P. Ascierto, M. Maio, 2019, Annals of Oncology.

[Dosimetric comparison of the helical tomotherapy, intensity-modulated radiotherapy and volumetric-modulated arc therapy in radical radiotherapy for esophageal cancer].

H. Ma, Y. Xu, P. Li, 2019, Zhonghua yi xue za zhi.

A multinational phase III randomized trial with or without consolidation chemotherapy using docetaxel and cisplatin after concurrent chemoradiation in inoperable stage III non-small cell lung cancer (CCheIN): Interim analysis.

Y. Wu, D. Heo, K. Park, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized, double-blind phase III study (VEG105192) of pazopanib (paz) versus placebo (pbo) in patients with advanced/metastatic renal cell carcinoma (mRCC): Updated safety results.

C. Sternberg, I. Davis, C. Szczylik, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

137P Phase I dose-finding study of a novel anti-CTLA-4 antibody ADG116 as monotherapy in patients with advanced solid tumors

A. Tolcher, X. Wang, S. Fischkoff, 2021, Annals of Oncology.

LBA32 Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study

B. Monk, I. Vergote, S. Pignata, 2020 .

7119 Genitourinary malignancies – Renal cancer Quality of life (QOL) in treatment-naïve and cytokine-pretreated patients with advanced renal cell carcinoma (RCC) treated with pazopanib: results from a phase III double-blind, placebo-controlled trial

M. Neary, A. Pickard, C. Sternberg, 2009 .